CBA Pharma Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Debt - PPP

  • Investors
  • 1

CBA Pharma General Information

Description

Developer of chemotherapy drugs intended for the effective treatment of cancer. The company therapies reverse multi-drug resistance in cancer cells and become part of a cancer treatment program that is administered before a cancer cell can become drug-resistant, enabling healthcare professionals to provide hope and opportunity for a normal life span with an improved quality of life to people with a life-threatening disease and reduce drug resistance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 670 Perimeter Drive
  • Lexington, KY 40517
  • United States
+1 (859)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 670 Perimeter Drive
  • Lexington, KY 40517
  • United States
+1 (859)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CBA Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Debt - PPP 16-Apr-2020 Completed Generating Revenue
6. Later Stage VC 29-Jan-2015 Completed Generating Revenue
5. Later Stage VC 05-Jun-2013 Completed Generating Revenue
4. Later Stage VC 25-Mar-2010 Completed Generating Revenue
3. Later Stage VC 16-Jun-2006 Completed Generating Revenue
2. Later Stage VC 09-Sep-2004 $70K $95K Completed Startup
1. Seed Round 22-Sep-2003 $25K $25K Completed Startup
To view CBA Pharma’s complete valuation and funding history, request access »

CBA Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of chemotherapy drugs intended for the effective treatment of cancer. The company therapies reverse multi-drug
Drug Discovery
Lexington, KY

Paris, France
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CBA Pharma Competitors (4)

One of CBA Pharma’s 4 competitors is Nanobiotix, a Formerly VC-backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nanobiotix Formerly VC-backed Paris, France
CytImmune Sciences Private Equity-Backed Rockville, MD
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Ayala Pharmaceuticals Corporation Wilmington, DE
To view CBA Pharma’s complete competitors history, request access »

CBA Pharma Patents

CBA Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9254323-B2 Method and products for enhancing cellular uptake of drug and dietary supplements Active 15-Mar-2013
US-20140275157-A1 Method and products for enhancing cellular uptake of drug and dietary supplements Active 15-Mar-2013
US-9517234-B2 Tetrandrine family pharmaceutical formulations and method Active 15-Mar-2013
US-10815243-B2 Tetrandrine family pharmaceutical formulations and method Active 15-Mar-2013
US-20140275137-A1 Tetrandrine family pharmaceutical formulations and method Active 15-Mar-2013 C07D491/147
To view CBA Pharma’s complete patent history, request access »

CBA Pharma Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Symetryx Corporation Venture Capital Minority
To view CBA Pharma’s complete investors history, request access »

CBA Pharma FAQs

  • When was CBA Pharma founded?

    CBA Pharma was founded in 1999.

  • Where is CBA Pharma headquartered?

    CBA Pharma is headquartered in Lexington, KY.

  • What industry is CBA Pharma in?

    CBA Pharma’s primary industry is Drug Discovery.

  • Is CBA Pharma a private or public company?

    CBA Pharma is a Private company.

  • What is CBA Pharma’s current revenue?

    The current revenue for CBA Pharma is .

  • How much funding has CBA Pharma raised over time?

    CBA Pharma has raised $9.5M.

  • Who are CBA Pharma’s investors?

    Symetryx Corporation has invested in CBA Pharma.

  • Who are CBA Pharma’s competitors?

    Nanobiotix, CytImmune Sciences, Inovio Pharmaceuticals, and Ayala Pharmaceuticals are competitors of CBA Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »